We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » BsUFA III Negotiations Feature Regulatory Science Pilot, Cost Estimates
BsUFA III Negotiations Feature Regulatory Science Pilot, Cost Estimates
A proposed regulatory science pilot program and the FDA’s cost estimates under the next iteration of the Biosimilar User Fee Act (BsUFA) program were the focus of discussions in a recent negotiation meeting.